Adjunctive Coronary Physiology Indicator
Estimates how much a narrowing actually restricts blood flow, from imaging rather than from a wire in the artery.
Seeing a narrowed artery on a scan does not tell you whether it is starving the heart muscle. Those are different questions, and the answer decides whether a patient gets a stent.
The traditional way to answer it is to thread a pressure wire into the artery during a catheter procedure. That is invasive, costs money, and carries risk.
Software in this group estimates the same thing from imaging that already exists. The word adjunctive in the FDA name is doing real work: it supports the decision, it does not replace the measurement.
Clearances per Year
What the FDA Actually Signed Off On
- FDA product code
- QXZ
- FDA name for it
- Adjunctive Epicardial Vascular Physiologic Status Indicator
- Rule number
- 21 CFR 870.2200
- Risk class
- Class 2
- Medical field
- Cardiovascular
Before You Sign Anything
- Ask how the estimate compared with invasive measurement in the validation study, including where it disagreed.
- Ask what image quality it needs, because the answer is usually stricter than a routine scan.
- Ask how your cath lab team wants disagreements resolved before you deploy it, not after.
Every Cleared Product, Newest First
Each row links to the FDA's own record. The number in the last column is the clearance number, which is the single best thing to ask a vendor for.
| Product | Company | Cleared | FDA record |
|---|---|---|---|
| Cleerly ISCHEMIA | Cleerly, Inc. | September 8, 2023 | K231335 |
Clearance data comes from the FDA's public 510(k) and device classification records through openFDA. A clearance means the FDA agreed the product is close enough to something already on the market, not that the FDA tested it in your hospital. It says nothing about accuracy in your patient mix, your scanners, or your workflow. Confirm the current status and the exact cleared indication on the FDA record before you buy.